Search - tctmd.com

Displaying 61 - 80 of 173

Sort: Relevancy | Date

News Conference News ACC 2020

Early Data Support TAVR in Bicuspid Valves, but Questions Remain

Michael O'Riordan

March 29, 2020

News Conference News ACC 2020

PARTNER 3: TAVR Now Noninferior to Surgery at 2 Years in Low-Risk Patients

Yael L. Maxwell

March 29, 2020

News Daily News

Bioprosthetic Valve Thrombosis Rare but Not Benign: New Insights

Yael L. Maxwell

February 28, 2020

News Conference News CRT 2020

Less Leaflet Thrombosis in Low-Risk TAVR Patients Treated With Oral Anticoagulation

Michael O'Riordan

February 26, 2020

News Daily News

Preemptive Stents Feasible for TAVR Patients at High Risk for Coronary Occlusion

Yael L. Maxwell

February 14, 2020

News Daily News

ACS After TAVR a Unique Condition With Poor Prognosis

Todd Neale

February 05, 2020

News Daily News

Routine Anticoagulation Seems Warranted After TMVR: Review

Todd Neale

December 04, 2019

News Conference News PCR London Valves 2019

Solid 2-Year Outcomes for Portico, With Paravalvular Leak Rare

Michael O'Riordan

November 20, 2019

News Conference News AHA 2019

Full GALILEO Results Confirm Harm With Rivaroxaban After TAVR

Todd Neale

November 17, 2019

News Conference News AHA 2019

AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials

Shelley Wood

November 11, 2019

Podcast TCTMD Talking Points

PARTNER 3 Low-Risk Computed Tomography Substudy: Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Valves

October 25, 2019

News Conference News TCT 2019

Leaflet Thickening and Impaired Motion No Worse With TAVR: PARTNER 3 CT

Michael O'Riordan

September 27, 2019

Presentation TCT 2019

PARTNER 3 Low-Risk Computed Tomography Substudy: Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Valves

Presenter: Raj Makkar

September 27, 2019

News Opinion Editor's Corner TCT 2019

TCT 2019 Day Two: Transcatheter Valves, New and Old

Shelley Wood

September 27, 2019

Presentation TCT 2019

Valve Leaflet Thickening and Thrombosis: Definitions, Frequency, Management, and Clinical Importance

Presenter: Lars Sondergaard

September 26, 2019

News Conference News TCT 2019

TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More

Shelley Wood

September 19, 2019

News Opinion Fellow Talk

What I Am Most Looking Forward to at TCT 2019

Mahesh V. Madhavan, MD

September 18, 2019

News Daily News

Oral Anticoagulation Post-AVR Safe but Not Routinely Needed: PARTNER II

Caitlin E. Cox

August 27, 2019

News Daily News

Antiplatelets Protective Post-TAVR in A-fib Patients: PARTNER II Data

Caitlin E. Cox

August 21, 2019

News Daily News

TAVR Bleeds Stand Apart From PCI-Related Events

Caitlin E. Cox

August 06, 2019

Advertisement

Early Data Support TAVR in Bicuspid Valves, but Questions Remain

PARTNER 3: TAVR Now Noninferior to Surgery at 2 Years in Low-Risk Patients

Bioprosthetic Valve Thrombosis Rare but Not Benign: New Insights

Less Leaflet Thrombosis in Low-Risk TAVR Patients Treated With Oral Anticoagulation

Preemptive Stents Feasible for TAVR Patients at High Risk for Coronary Occlusion

ACS After TAVR a Unique Condition With Poor Prognosis

Routine Anticoagulation Seems Warranted After TMVR: Review

Solid 2-Year Outcomes for Portico, With Paravalvular Leak Rare

Full GALILEO Results Confirm Harm With Rivaroxaban After TAVR

AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials

PARTNER 3 Low-Risk Computed Tomography Substudy: Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Valves

Leaflet Thickening and Impaired Motion No Worse With TAVR: PARTNER 3 CT

PARTNER 3 Low-Risk Computed Tomography Substudy: Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Valves

TCT 2019 Day Two: Transcatheter Valves, New and Old

Valve Leaflet Thickening and Thrombosis: Definitions, Frequency, Management, and Clinical Importance

TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More

What I Am Most Looking Forward to at TCT 2019

Oral Anticoagulation Post-AVR Safe but Not Routinely Needed: PARTNER II

Antiplatelets Protective Post-TAVR in A-fib Patients: PARTNER II Data

TAVR Bleeds Stand Apart From PCI-Related Events

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content